LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 47.83 | 770.25 | 2400 | 6223 | 0.3856 | 0.4580 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 50.05 | 770.25 | 1511 | 6629 | 0.2279 | 0.2423 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 50.05 | 770.25 | 2620 | 6629 | 0.3952 | 0.4832 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 52.27 | 770.25 | 1563 | 7058 | 0.2214 | 0.2478 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 52.27 | 770.25 | 2797 | 7058 | 0.3962 | 0.4971 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 54.49 | 770.25 | 1642 | 7555 | 0.2173 | 0.2583 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 54.49 | 770.25 | 2981 | 7555 | 0.3946 | 0.5081 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 56.71 | 770.25 | 1798 | 8001 | 0.2247 | 0.2854 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 56.71 | 770.25 | 3276 | 8001 | 0.4094 | 0.5353 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 58.94 | 770.25 | 1823 | 8444 | 0.2159 | 0.2832 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 58.94 | 770.25 | 3469 | 8444 | 0.4108 | 0.5459 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 61.16 | 770.25 | 1904 | 8892 | 0.2141 | 0.2923 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 61.16 | 770.25 | 3800 | 8892 | 0.4274 | 0.5719 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 63.39 | 770.25 | 2055 | 9326 | 0.2204 | 0.3136 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 63.39 | 770.25 | 3902 | 9326 | 0.4184 | 0.5698 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 65.61 | 770.25 | 2106 | 9736 | 0.2163 | 0.3163 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 65.61 | 770.25 | 4373 | 9736 | 0.4492 | 0.6072 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 67.83 | 770.25 | 2279 | 10078 | 0.2261 | 0.3397 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 67.83 | 770.25 | 4660 | 10078 | 0.4624 | 0.6245 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 70.05 | 770.25 | 2475 | 10413 | 0.2377 | 0.3644 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 70.05 | 770.25 | 4836 | 10413 | 0.4644 | 0.6307 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 72.27 | 770.25 | 2614 | 10730 | 0.2436 | 0.3792 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 72.27 | 770.25 | 5268 | 10730 | 0.4909 | 0.6585 | MN20160304_L02 | I16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 74.50 | 770.25 | 2727 | 10991 | 0.2481 | 0.3905 | MN20160304_L02 | F22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 74.50 | 770.25 | 5647 | 10991 | 0.5138 | 0.6812 | MN20160304_L02 | I16 |